Ocular manifestations of connective tissue disease.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D002648:Child; D002738:Chloroquine / Q000009:adverse effects; D003240:Connective Tissue Diseases / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D005128:Eye Diseases / Q000209:etiology* / Q000503:physiopathology; D005260:Female; D013700:Giant Cell Arteritis / Q000503:physiopathology; D006046:Gold / Q000009:adverse effects; D006801:Humans; D007249:Inflammation / Q000503:physiopathology; D007636:Keratoacanthoma / Q000503:physiopathology; D008297:Male; D009336:Necrosis; D012590:Sclera / Q000473:pathology; D012859:Sjogren's Syndrome / Q000503:physiopathology; D014605:Uveitis / Q000503:physiopathology; D014606:Uveitis, Anterior / Q000503:physiopathology
D000305:Adrenal Cortex Hormones; D006046:Gold; D002738:Chloroquine